Walgreens Boots Alliance Inc (WBA) Holdings Reduced by Tdam USA Inc.

Tdam USA Inc. trimmed its holdings in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 51.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 46,615 shares of the pharmacy operator’s stock after selling 50,334 shares during the period. Tdam USA Inc.’s holdings in Walgreens Boots Alliance were worth $3,600,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of WBA. Commonwealth Bank of Australia boosted its stake in shares of Walgreens Boots Alliance by 139.5% in the 2nd quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after buying an additional 26,893 shares during the last quarter. Andra AP fonden boosted its stake in shares of Walgreens Boots Alliance by 6.9% in the 3rd quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock worth $4,811,000 after buying an additional 4,000 shares during the last quarter. IBM Retirement Fund boosted its stake in shares of Walgreens Boots Alliance by 88.1% in the 2nd quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock worth $2,004,000 after buying an additional 10,729 shares during the last quarter. Schwab Charles Investment Management Inc. boosted its stake in shares of Walgreens Boots Alliance by 5.4% in the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after buying an additional 154,995 shares during the last quarter. Finally, Birinyi Associates Inc. boosted its stake in shares of Walgreens Boots Alliance by 9.0% in the 2nd quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after buying an additional 750 shares during the last quarter. Institutional investors and hedge funds own 61.18% of the company’s stock.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total value of $184,324.32. Following the sale, the director now directly owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John Anthony Lederer bought 20,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the completion of the acquisition, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is owned by company insiders.

Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $72.62 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 0.59 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $71,919.63, a PE ratio of 19.21, a price-to-earnings-growth ratio of 1.30 and a beta of 1.22. Walgreens Boots Alliance Inc has a twelve month low of $63.82 and a twelve month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, beating the Zacks’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion for the quarter, compared to analysts’ expectations of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The business’s quarterly revenue was up 5.3% on a year-over-year basis. During the same period last year, the firm earned $1.07 earnings per share. equities research analysts predict that Walgreens Boots Alliance Inc will post 5.54 EPS for the current year.

Walgreens Boots Alliance announced that its Board of Directors has initiated a stock buyback program on Wednesday, October 25th that permits the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization permits the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase programs are typically a sign that the company’s management believes its stock is undervalued.

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th were issued a dividend of $0.40 per share. The ex-dividend date was Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.20%. Walgreens Boots Alliance’s dividend payout ratio is presently 42.33%.

WBA has been the topic of several analyst reports. Needham & Company LLC reiterated a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research report on Sunday, September 10th. Jefferies Group reiterated a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research report on Thursday, September 7th. Mizuho set a $94.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Tuesday, October 24th. Royal Bank of Canada reiterated a “buy” rating and set a $88.00 target price on shares of Walgreens Boots Alliance in a research report on Wednesday, October 25th. Finally, Loop Capital set a $90.00 target price on Walgreens Boots Alliance and gave the company a “buy” rating in a research report on Thursday, October 26th. One equities research analyst has rated the stock with a sell rating, eight have issued a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $86.60.

ILLEGAL ACTIVITY WARNING: “Walgreens Boots Alliance Inc (WBA) Holdings Reduced by Tdam USA Inc.” was originally posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.chaffeybreeze.com/2018/01/02/walgreens-boots-alliance-inc-wba-holdings-reduced-by-tdam-usa-inc.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply